|
Q1 FY2016
As of Sep 30, 2015
|
Q4 FY2015
As of Jun 30, 2015
|
Q3 FY2015
As of Mar 31, 2015
|
Q2 FY2015
As of Dec 31, 2014
|
Q1 FY2015
As of Sep 30, 2014
|
Q4 FY2014
As of Jun 30, 2014
|
Q3 FY2014
As of Mar 31, 2014
|
Q2 FY2014
As of Dec 31, 2013
|
Q1 FY2014
As of Sep 30, 2013
|
Q4 FY2013
As of Jun 30, 2013
|
Q3 FY2013
As of Mar 31, 2013
|
Q2 FY2013
As of Dec 31, 2012
|
Q1 FY2013
As of Sep 30, 2012
|
Q4 FY2012
As of Jun 30, 2012
|
Q3 FY2012
As of Mar 31, 2012
|
Q2 FY2012
As of Dec 31, 2011
|
Q1 FY2012
As of Sep 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Fiduciary assets | |||||||||||||||||
| Short-term investments | |||||||||||||||||
| Receivables from clients: | |||||||||||||||||
| Billed, net of allowances of $11,623 and $7,665 | |||||||||||||||||
| Unbilled, at estimated net realizable value | |||||||||||||||||
| Current receivables, net | |||||||||||||||||
| Other current assets | |||||||||||||||||
| Current assets held for sale | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Fixed assets, net | |||||||||||||||||
| Deferred income taxes | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Intangible assets, net | |||||||||||||||||
| Investments of consolidated variable interest entity | |||||||||||||||||
| Other assets | |||||||||||||||||
| Noncurrent assets held for sale | |||||||||||||||||
| Total Assets | |||||||||||||||||
| Liabilities and Equity | |||||||||||||||||
| Liabilities | |||||||||||||||||
| Accounts payable, accrued liabilities and deferred income | |||||||||||||||||
| Employee-related liabilities | |||||||||||||||||
| Fiduciary liabilities | |||||||||||||||||
| Term loan - current | |||||||||||||||||
| Other current liabilities | |||||||||||||||||
| Current liabilities held for sale | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Revolving credit facility | |||||||||||||||||
| Term loan | |||||||||||||||||
| Accrued retirement benefits and other employee-related liabilities | |||||||||||||||||
| Professional liability claims reserve | |||||||||||||||||
| Other noncurrent liabilities | |||||||||||||||||
| Noncurrent liabilities held for sale | |||||||||||||||||
| Total Liabilities | |||||||||||||||||
| Stockholders’ Equity | |||||||||||||||||
| Class A Common Stock — $0.01 par value: 300,000,000 shares authorized; 74,552,661 issued and 69,441,212 and 69,281,754 outstanding | |||||||||||||||||
| Common Class A | |||||||||||||||||
| Common Class B | |||||||||||||||||
| Total class A Common Stock — $0.01 par value: 300,000,000 shares authorized; 74,552,661 issued and 69,441,212 and 69,281,754 outstanding | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Treasury stock, at cost — 5,111,449 and 5,270,907 shares | |||||||||||||||||
| Retained earnings | |||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||
| Total Stockholders’ Equity | |||||||||||||||||
| Non-controlling interest | |||||||||||||||||
| Total Equity | |||||||||||||||||
| Total Liabilities and Total Equity | |||||||||||||||||
Loading...
